BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baggus EMR, Hadjivassiliou M, Cross S, Penny H, Urwin H, Watson S, Woodward JM, Sanders DS. How to manage adult coeliac disease: perspective from the NHS England Rare Diseases Collaborative Network for Non-Responsive and Refractory Coeliac Disease.Frontline Gastroenterol. 2020;11:235-242. [PMID: 32419915 DOI: 10.1136/flgastro-2019-101191] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Ashton JJ, Smith R, Smith T, Beattie RM. Investigating coeliac disease in adults. BMJ 2020;369:m2176. [PMID: 32554547 DOI: 10.1136/bmj.m2176] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Catassi C, Verdu EF, Bai JC, Lionetti E. Coeliac disease. The Lancet 2022;399:2413-26. [DOI: 10.1016/s0140-6736(22)00794-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 D'Avino P, Serena G, Kenyon V, Fasano A. An updated overview on celiac disease: from immuno-pathogenesis and immuno-genetics to therapeutic implications.Expert Rev Clin Immunol. 2021;17:269-284. [PMID: 33472447 DOI: 10.1080/1744666X.2021.1880320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Klonarakis M, Andrews CN, Raman M, Panaccione R, Ma C. Review article: therapeutic targets for the pharmacologic management of coeliac disease-the future beyond a gluten-free diet. Aliment Pharmacol Ther 2022;55:1277-96. [PMID: 35229332 DOI: 10.1111/apt.16846] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Parker S, Palsson O, Sanders DS, Simren M, Sperber AD, Törnblom H, Urwin H, Whitehead W, Aziz I. Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00758-8. [PMID: 34298190 DOI: 10.1016/j.cgh.2021.07.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang M, Yu M, Kong WJ, Cui M, Gao F. Association between intestinal neoplasms and celiac disease: A review. World J Gastrointest Oncol 2021;13:1017-28. [PMID: 34616509 DOI: 10.4251/wjgo.v13.i9.1017] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Soderquist CR, Bhagat G. Cellular and molecular bases of refractory celiac disease. Int Rev Cell Mol Biol 2021;358:207-40. [PMID: 33707055 DOI: 10.1016/bs.ircmb.2020.12.001] [Reference Citation Analysis]
8 Kivelä L, Caminero A, Leffler DA, Pinto-Sanchez MI, Tye-Din JA, Lindfors K. Current and emerging therapies for coeliac disease. Nat Rev Gastroenterol Hepatol 2021;18:181-95. [PMID: 33219355 DOI: 10.1038/s41575-020-00378-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
9 Penny HA, Raju SA, Sanders DS. Progress in the serology-based diagnosis and management of adult celiac disease. Expert Rev Gastroenterol Hepatol 2020;14:147-54. [PMID: 32011187 DOI: 10.1080/17474124.2020.1725472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]